SciRhom GmbH, a biotech startup co-founded by Hospital for Special Surgery (HSS), recently secured a 63 million euro (US$70 million) Series A financing round to support the clinical development of its novel drug candidate, SR-878. The round was …

HSS researchers found that suppressing the inflammatory protein iRhom2 reduced inflammation and prevented kidney damage in those with lupus, Lupus News Today reported. Findings indicated that the protein ADAM17 plays a key role in inflammatory …

A protein that helps regulate the body’s inflammatory system appears to play a critical role in causing kidney damage in patients with lupus and could be a target for future treatments for autoimmune disease, a new study has found. Researchers at …